These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 15753674
21. A quantitative analysis of orbital soft tissue in Graves' disease based on B-mode ultrasonography. Yamamoto K, Itoh K, Yoshida S, Saito K, Sakamoto Y, Matsuda A, Saito T, Kuzuya T. Endocrinol Jpn; 1979 Apr; 26(2):255-61. PubMed ID: 582582 [Abstract] [Full Text] [Related]
30. Affinity purification of orbital membrane antigens for the study of the pathogenesis of Graves' ophthalmopathy. Salvi M, Bingoye F, Chung F, Wall JR. J Clin Endocrinol Metab; 1988 May; 66(5):939-45. PubMed ID: 3360902 [Abstract] [Full Text] [Related]
32. Untreated Graves' disease patients without clinical ophthalmopathy demonstrate a high frequency of extraocular muscle (EOM) enlargement by magnetic resonance. Villadolid MC, Yokoyama N, Izumi M, Nishikawa T, Kimura H, Ashizawa K, Kiriyama T, Uetani M, Nagataki S. J Clin Endocrinol Metab; 1995 Sep; 80(9):2830-3. PubMed ID: 7673432 [Abstract] [Full Text] [Related]
34. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease. Noh JY, Hamada N, Inoue Y, Abe Y, Ito K, Ito K. Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459 [Abstract] [Full Text] [Related]
37. Human retroocular fibroblasts in vitro: a model for the study of Graves' ophthalmopathy. Bahn RS, Gorman CA, Woloschak GE, David CS, Johnson PM, Johnson CM. J Clin Endocrinol Metab; 1987 Oct; 65(4):665-70. PubMed ID: 3654911 [Abstract] [Full Text] [Related]